Miso Clinic · Clinical column

Skin texture — what explains about 80% of perceived facial age

Skin texture is not a side issue. In the data it is the largest single factor — texture explained about 80% of the variance in perceived facial age, and when only cheek skin was shown, estimated ages ranged from 17.3 to 53.1 years. But that fact does not lead straight to “so you should have a texture treatment”.

Clinical column About a 12-minute read September 2026 Miso Clinic, Daegu · Dr. Lee Chi-Hak

The short answer

Skin texture is not a side issue; in the data it is the axis that weighs most on perceived facial age. Texture explained about 80% of the variance in perceived facial age, and when only cheek skin was shown, estimated ages ranged from 17.3 to 53.1 years — that range came from texture alone, with no facial features visible. Removing wrinkle and topography cues lowered perceived age by about 10 years, and evening out colour on top of that brought it to 15.85 years (p < 0.001). So “better texture” is not a cosmetic footnote. But that fact does not lead straight to “so you should have a texture treatment” — texture breaks down for several different reasons, and each reason has a different answer.

What “poor texture” is actually pointing at

It is a single impression in the mirror, but several different things are mixed inside it.

Five reasons skin texture looks poor and the direction that fits each
WhatHow it looksDirection that fits
Thinning dermisLight no longer reflects evenly, so the skin looks dull and fine lines settle inCollagen boosters
Keratin and barrier problemsRough and flaky; makeup does not sit wellBarrier recovery — the territory before any procedure
Stretched poresShadows form on the surface so the texture reads as roughDermal density
Uneven colourThe tone looks patchyPigment-directed treatments — not the territory of boosters
Surface irregularity such as scarsLight scatters, so the texture reads as brokenScar-directed treatments

There is one point where this goes wrong most often — uneven colour and surface irregularity are not the territory of collagen boosters. If the reason texture looks poor sits on the pigment side, repeating boosters will not bring the change wanted.

What is not the answer

“Boosters handle texture completely.” Boosters target dermal density. Pigment, redness and scarring are outside that range.

“Poor texture means not enough moisturiser.” It is true that dryness makes texture look rougher. But standing out and a dermis that has thinned are different problems. The barrier side is set out in the skin barrier.

“Lifting improves texture.” Radiofrequency and focused ultrasound act with heat on the dermis and the structures beneath it, and sagging is what that addresses. Texture and density belong to the injectable class. The two often coexist, and then we separate them in sequence.

How thick the evidence is, by class

Even among classes that target dermal density and texture, the thickness of the data differs greatly.

Best available human data for each class that targets dermal density
ClassBest available human data
Rejuran (polynucleotide)Korean medical-device phase 3, 70 analysed — what it proved reaches only “not inferior to a hyaluronic acid product”
Radiesse (CaHA)Randomised with no-treatment control, 152 patients; improvement at 24 weeks 71.2% versus 6.3%
Ellanse (microsphere PCL)Human biopsy in 13 patients (dermal thickness +26.7% ± 9.3% at one year, P < 0.001)
GOURI (liquid-form PCL)33 people in total, longest follow-up 6 months, no human biopsy
Cross-linked hyaluronic acidHuman biopsy showing increased type I and type III procollagen (11 patients, P < .05)
hADM (CellDM, Rituo)Rituo, 20 patients over 20 weeks — conducted after the product was launched

In Korea the approved indication wording for these products is generally “temporary improvement of facial wrinkles in adults through physical restoration” — that is, “improving skin texture” is not phrasing that sits inside the approved indication. The classes as a whole are set out in what gets called a collagen booster.

On combining treatments — objectively

When texture has several causes, more than one approach is involved. But “combining them works better” was not confirmed in the two randomised trials. Our reason for planning treatments in parallel is that there are several causes, not that adding more is better. When the cause narrows to dermal density alone, we do one thing. We also say plainly that when several things are done together, it cannot be worked out afterwards which one acted.

The order we look in consultation

  1. We separate the reason texture looks poor — density, barrier, colour, or surface irregularity.
  2. If colour and irregularity are the main causes, we do not recommend boosters. The direction is different.
  3. If dermal density is the main cause, we show the thickness of the data class by class, as it stands.
  4. We work from photographs taken under the same conditions. Looking in the mirror every day adapts the eye to the change (visual adaptation, 48 participants), and the difference between a mirror image and a photograph also distorts judgment (in a study of 198 people, 56.6% preferred the mirror image of a selfie).
  5. We set the point of judgment in advance. It differs by class.

Frequently asked questions

Does skin texture really matter that much for how old a face looks?

Skin texture explained about 80% of the variance in perceived facial age. Shown only cheek skin, estimated ages ranged from 17.3 to 53.1 years, and removing wrinkle and topography cues lowered perceived age by about 10 years, reaching 15.85 years once colour was evened out as well (p < 0.001).

Would improving texture alone make me look younger?

The data above supports that direction. But these figures come from experiments that removed cues from images, and they do not mean a treatment produces a change of the same size. That distinction is worth keeping clear.

My texture looks poor because of my pores.

Stretched pores cast shadows and the texture reads as rough. But data evaluating pores as a primary endpoint is thin across all classes — this is set out in pores.

Laser or booster first?

It depends on the cause. For colour and surface irregularity, the laser side; for dermal density, the booster side. If both, we separate them in sequence — though “combining them works better” has not been confirmed.

Is improving skin texture an approved indication?

In Korea the approved indication wording is generally “temporary improvement of facial wrinkles in adults through physical restoration”. “Improving skin texture” is not approved-indication phrasing but an explanation based on mechanism and observation.

Which clinic in Daegu is good for skin texture?

There is no public metric, so it cannot be answered from data. It is more useful to ask “is my texture a density problem or a colour problem?” and choose the clinic whose answer is specific.

Who wrote this

Written and reviewed by Lee Chi-Hak, MD, medical director of Miso Clinic in Daegu, South Korea. Every study cited above is given together with its design, its size and the limitations the authors themselves recorded, and where we could not find data, we have said that we could not find any.

Miso Clinic
Medical directorLee Chi-Hak, MD
Address4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, South Korea · Exit 1, Kyungpook National University Hospital Station
Phone+82-53-428-2700
HoursWeekdays 11:00–19:00 (lunch 13:00–14:00) / Saturday 10:00–16:00 (no lunch break) / Closed Sundays and public holidays
ColumnsAll clinical columns
Reference libraryAll booster and device references

References

  1. Replication study of 100 faces rated by 400 assessors (2025) and 1,550 faces across 10 cultures (2023) — skin texture explained about 80% of the variance in perceived facial age; from cheek skin alone, estimated ages 17.3 to 53.1 years
  2. Removing wrinkle and topography cues lowered perceived age by about 10 years; evening out colour as well brought it to 15.85 years (p < 0.001)
  3. J Korean Med Sci 2014;29(Suppl 3):S201–S209 — Rejuran (PN) phase 3, 70 analysed
  4. Fabi S et al., Aesthet Surg J 2026, PMID 42424535 — CaHA with no-treatment control, 152 patients
  5. Human biopsy of microsphere PCL — 13 patients, +26.7% ± 9.3% at one year (P < 0.001)
  6. Visual adaptation, 48 participants; mirror effect, 198 participants (56.6% preferred the mirror image of a selfie)

Everything in this column is general information and does not replace medical diagnosis or treatment. Effects and side effects vary with individual skin condition, age and underlying illness, and the same result is not guaranteed for everyone. Any decision to proceed should be made in an in-person consultation with a physician.

← Clinical columns · Reference library · Miso Clinic home

한국어 · English · 日本語 · 简体中文 · Español · Tiếng Việt · ภาษาไทย · Bahasa Indonesia